AI Tuberculosis Screening Could Cut Costs by 23% in Rural Philippines Health Units

AI Tuberculosis Screening Shows Promise for Cost-Effectiveness in Rural Philippines

Researchers from Ateneo de Manila University have demonstrated that AI tuberculosis screening could significantly reduce costs while expanding access to early TB detection in rural Philippines1

1

. The study, published in BMC Health Services Research in August 2026, examined AI-assisted chest radiograph interpretation as a solution to address healthcare gaps in geographically isolated communities where radiologist availability remains severely limited2

2

.

Dr. Harold Chiu, Dr. Bryan Lao, and Dr. Gloanne Adolor developed a decision-analytic model based on a theoretical annual cohort of 1,000 presumptive TB patients undergoing chest radiography in rural health units. Their analysis considered costs and outcomes over five years, including AI software and operating expenses, radiologist reading fees, and confirmatory GeneXpert testing1

1

. The findings carry particular weight given that an estimated 739,000 people in the Philippines developed tuberculosis in 2024 alone, accounting for 6.8% of the 10.8 million TB cases worldwide according to the World Health Organization2

2

.

Significant Cost Reduction Through AI-Assisted Chest Radiograph Interpretation

The model-based projections revealed that affordable tuberculosis screening using AI would entail an estimated annual cost of Php 877,330, compared with Php 1.14 million for manual X-ray interpretation1

1

. When divided across the 1,000 individuals screened, this translated to approximately Php 877 per person with AI-assisted interpretation, versus about Php 1,142 per person using manual interpretation—a 23% cost reduction that could prove transformative for resource-constrained public health systems2

2

.

The cost-effectiveness extends beyond mere numbers. In rural health units, patients often face prolonged waiting periods for radiologists or teleradiology services to interpret chest radiographs. These delays can mean another trip to a health facility, additional expenses, time away from work, or a missed opportunity for continued care—barriers that AI could help eliminate1

1

.

Extending Expert-Level TB Screening to Underserved Communities

The researchers emphasize that the significance of AI goes beyond efficiency metrics. "For resource-constrained communities, the most important question is therefore not whether AI can outperform or assist an expert reader, but whether it can extend expert-level support to places where expertise is scarce in a way that is affordable, sustainable, and equitable," the researchers stated2

2

. This perspective shifts the conversation from technological capability to practical accessibility for underserved communities where medical expertise remains scarce.

If properly integrated into existing TB programs through portable digital X-rays and systems that can operate with limited connectivity, AI could bring TB screening closer to populations who need it most. The goal should not be to introduce another high-tech tool into healthcare, but to narrow existing geographic disparities that leave vulnerable populations without timely diagnosis1

1

.

Local Conditions and Implementation Considerations

The findings also highlight important nuances regarding local conditions and implementation strategies. When lower manual or teleradiology reading fees were used in the model, or when diagnostic performance estimates from a Philippine scenario were applied, AI remained more effective but was no longer necessarily cost-saving2

2

. This variability underscores the need for context-specific evaluation rather than blanket adoption.

The study acknowledges its limitations, being based on a theoretical cohort and assumptions about costs and diagnostic accuracy. AI-assisted findings would still require confirmatory testing through methods like GeneXpert. Rather than immediate nationwide adoption, the researchers recommend starting with targeted pilot implementation in underserved rural health units, alongside local validation, quality assurance, monitoring, and budget assessment1

1

.

For a country carrying a significant share of the world's tuberculosis burden while struggling to provide universal healthcare to its citizens, the question may ultimately be less about bringing the newest technology into healthcare and more about where that technology can help deliver expertise to meet the realities of people with the least access to it. The path forward involves careful pilot implementation, rigorous quality assurance, and continuous monitoring to ensure AI tuberculosis screening serves those who need it most while maintaining diagnostic accuracy and cost-effectiveness in real-world settings across rural Philippines.